The U.S. Trade Representative removed Israel from the Special 301...
The U.S. Trade Representative removed Israel from the Special 301 “priority” watch list for countries with troubling intellectual property practices, and placed it on the regular watch list, the agency said Monday. According to the USTR announcement, Israel’s move to…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
the regular list is based on the country’s introduction of three proposals aimed at improving its pharmaceutical patent system. The proposals came about as a result of a memorandum of understanding between Israel and the U.S. signed in 2010. The memorandum said the U.S. would remove Israel from the watch list once the new laws are enacted. The introduction of these proposals demonstrate “the commitment of both the United States and Israel to providing transparent, efficient and effective patent systems for innovative and generic medicine producers,” USTR Ron Kirk said in a statement.